Drug Fix: Potential Nondisclosure Agreements For US FDA Staff, Hiring Threatens User Fee Reductions

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the potential impact a mandated nondisclosure agreement could have on US Food and Drug Administration activities and its employees (:34), as well as the changes the agency’s hiring push caused to user fee reauthorization efforts (13:50).

More On These Topics From The Pink Sheet

Proposed Government Nondisclosure Agreement Could Include US
FDA Pre-Decisional Memos: insights.citeline.com/pink-sheet/product-revie…

US FDA Hiring Push Threatens Industry Efforts To
Contain, Lower User Fees: insights.citeline.com/pink-sheet/pathways-and-…